Similar articles

• Immunological aspects of motor neuron disease.

  Shy ME. Shy ME. Res Publ Assoc Res Nerv Ment Dis. 1990;68:241-56. Res Publ Assoc Res Nerv Ment Dis. 1990. PMID: 2183314 Review. No abstract available.
• Sera from patients with motor neuron disease and associated paraproteinaemia fail to inhibit experimentally induced sprouting of motor nerve terminals.

  Donaghy M, Duchen LW. Donaghy M, et al. J Neurol Neurosurg Psychiatry. 1986 Jul;49(7):817-9. doi: 10.1136/jnnp.49.7.817. J Neurol Neurosurg Psychiatry. 1986. PMID: 3746310 Free PMC article.
• Monoclonal gammopathy and motor neuron disease.

  Sadiq SA, Latov N. Sadiq SA, et al. Adv Neurol. 1991;56:413-20. Adv Neurol. 1991. PMID: 1713014 Review. No abstract available.
• Motor neuron disease and paraproteinemia.

  Rudnicki S, Chad DA, Drachman DA, Smith TW, Anwer UE, Levitan N. Rudnicki S, et al. Neurology. 1987 Feb;37(2):335-7. doi: 10.1212/wnl.37.2.335. Neurology. 1987. PMID: 3808319
• Serum immunoglobulin and complement (C3) levels: a study in adults with idiopathic, chronic polyneuropathies and motor neuron diseases.

  Whitaker JN, Sciabbarrasi J, Engel WK, Warmolts JR, Strober W. Whitaker JN, et al. Neurology. 1973 Nov;23(11):1164-73. doi: 10.1212/wnl.23.11.1164. Neurology. 1973. PMID: 4355675 No abstract available.